Baird Medical Investment Holdings Ltd. $(BDMD)$, a leader in minimally invasive Microwave Ablation $(MWA)$ technology, has announced a strategic partnership with Stonewood Key Capital, a New Zealand-based investment management firm. This collaboration aims to accelerate Baird Medical's global commercialization efforts by leveraging the Hainan Free Trade Port as a central hub for cross-border operations and supply chain management. The agreement is expected to enhance capital allocation efficiency and support the company's growth in the healthcare sector, particularly for minimally invasive therapies targeting thyroid and other soft tissue conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baird Medical Investment Holdings Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE70325) on January 26, 2026, and is solely responsible for the information contained therein.